Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...

Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm. The post New state-of-the-art test identifies ...

Annual Congress was host to a renal cell carcinoma abstract session. Dr. Huebner-Resch presented her team’s initial real-world experience using [89 Zr]Zr-girentuximab PET/CT in the routine evaluation ...

Stage 1 mixed cellularity Hodgkin lymphoma is often highly treatable, and many patients achieve long-term remission after frontline therapy. Advances in chemotherapy, radiation techniques and targeted ...

Primary tracheal malignancies are extremely rare, accounting for less than 0.1 per cent of all cancers, with an incidence of 2–3 cases per million per year ...

Annual Congress was host to a renal cell carcinoma abstract session. Dr. David Liu presented results from ZIRCON-X, a post-hoc analysis of the phase 3 ZIRCON study evaluating the potential impact of ...

United Imaging, a global innovator in AI-powered advanced medical imaging technologies and intelligent healthcare solutions, showcased its comprehensive innovation portfolio at ECR 2026 with the ...

New findings from the phase III PRIMARY2 trial presented at EAU26 suggest that PSMA PET/CT imaging after inconclusive or reassuring MRI can safely reduce prostate biopsies by about 50 percent without ...